Lykka Labs shares rally 7% on CDSCO nod for diabetic neuropathy pain drug 0 15.10.2024 07:33 Business Standard Lyka Labs shares rose as the company announced that it has received the CDSCO approval for manufacturing & marketing of of Pregabalin Gel 8% w/w for use in patients with Diabetic Neuropathic Pain. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
